SHOX and sex difference in height: a hypothesis

The mean height is taller in males than in females, except for early teens. In this regard, previous studies have revealed that (1) distribution of the mean adult heights in subjects with disorders accompanied by discordance between sex chromosome complement and bioactive sex steroids and in control...

Full description

Saved in:
Bibliographic Details
Main Authors: Tsutomu Ogata, Atsushi Hattori, Maki Fukami
Format: Article
Language:English
Published: The Japan Endocrine Society 2025-01-01
Series:Endocrine Journal
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/endocrj/72/1/72_EJ24-0249/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591916869353472
author Tsutomu Ogata
Atsushi Hattori
Maki Fukami
author_facet Tsutomu Ogata
Atsushi Hattori
Maki Fukami
author_sort Tsutomu Ogata
collection DOAJ
description The mean height is taller in males than in females, except for early teens. In this regard, previous studies have revealed that (1) distribution of the mean adult heights in subjects with disorders accompanied by discordance between sex chromosome complement and bioactive sex steroids and in control subjects (the British height standards) indicates that, of the ~12.5 cm of sex difference in the mean adult height, ~9 cm is accounted for by the difference in the sex chromosome complement and the remaining ~3.5 cm is explained by the dimorphism in sex steroids (primarily due to the growth-promoting effect of gonadal androgens); (2) according to the infancy-childhood-puberty growth model, the sex difference in the childhood growth function produces height differences of ~1 cm in childhood and 8–10 cm at 18–20 years of age, whereas the sex difference in the pubertal growth function yields height difference of ~4.5 cm at 18–20 years of age; and (3) SHOX expression and methylation analyses using knee cartilage tissues and cultured chondrocytes have shown lower SHOX expression levels in female samples than in male samples and methylation patterns consistent with partial spreading of X-inactivation affecting SHOX in female samples. These findings suggest that small but persistent sex difference in SHOX expression dosage leads to the variation in the sex steroid independent childhood growth function, thereby yielding the sex difference in height which remains small in childhood but becomes obvious in adulthood.
format Article
id doaj-art-7e77c4cc75df44a18022cdcf00773da2
institution Kabale University
issn 1348-4540
language English
publishDate 2025-01-01
publisher The Japan Endocrine Society
record_format Article
series Endocrine Journal
spelling doaj-art-7e77c4cc75df44a18022cdcf00773da22025-01-22T05:36:47ZengThe Japan Endocrine SocietyEndocrine Journal1348-45402025-01-01721374210.1507/endocrj.EJ24-0249endocrjSHOX and sex difference in height: a hypothesisTsutomu Ogata0Atsushi Hattori1Maki Fukami2Departments of Pediatrics and Biochemistry, Hamamatsu University School of Medicine, Hamamatsu 431-3192, JapanDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, JapanDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, JapanThe mean height is taller in males than in females, except for early teens. In this regard, previous studies have revealed that (1) distribution of the mean adult heights in subjects with disorders accompanied by discordance between sex chromosome complement and bioactive sex steroids and in control subjects (the British height standards) indicates that, of the ~12.5 cm of sex difference in the mean adult height, ~9 cm is accounted for by the difference in the sex chromosome complement and the remaining ~3.5 cm is explained by the dimorphism in sex steroids (primarily due to the growth-promoting effect of gonadal androgens); (2) according to the infancy-childhood-puberty growth model, the sex difference in the childhood growth function produces height differences of ~1 cm in childhood and 8–10 cm at 18–20 years of age, whereas the sex difference in the pubertal growth function yields height difference of ~4.5 cm at 18–20 years of age; and (3) SHOX expression and methylation analyses using knee cartilage tissues and cultured chondrocytes have shown lower SHOX expression levels in female samples than in male samples and methylation patterns consistent with partial spreading of X-inactivation affecting SHOX in female samples. These findings suggest that small but persistent sex difference in SHOX expression dosage leads to the variation in the sex steroid independent childhood growth function, thereby yielding the sex difference in height which remains small in childhood but becomes obvious in adulthood.https://www.jstage.jst.go.jp/article/endocrj/72/1/72_EJ24-0249/_html/-char/enheighticp growth modelsex differenceshoxx-inactivation
spellingShingle Tsutomu Ogata
Atsushi Hattori
Maki Fukami
SHOX and sex difference in height: a hypothesis
Endocrine Journal
height
icp growth model
sex difference
shox
x-inactivation
title SHOX and sex difference in height: a hypothesis
title_full SHOX and sex difference in height: a hypothesis
title_fullStr SHOX and sex difference in height: a hypothesis
title_full_unstemmed SHOX and sex difference in height: a hypothesis
title_short SHOX and sex difference in height: a hypothesis
title_sort shox and sex difference in height a hypothesis
topic height
icp growth model
sex difference
shox
x-inactivation
url https://www.jstage.jst.go.jp/article/endocrj/72/1/72_EJ24-0249/_html/-char/en
work_keys_str_mv AT tsutomuogata shoxandsexdifferenceinheightahypothesis
AT atsushihattori shoxandsexdifferenceinheightahypothesis
AT makifukami shoxandsexdifferenceinheightahypothesis